In this edition of Clinical Lab Chat, Director of Business Intelligence Chris Wolski discusses with Courtney Noah, PhD, VP of Scientific Affairs at BioIVT, how blood-based biofluid testing is poised to revolutionize cancer diagnostics.
Among the topics they dig into are:
The benefits of blood-based biofluid testing over traditional, more invasive methods.
How biofluid testing saves money and improves access for patients.
How labs can add blood-based biofluid testing onto their diagnostic menus.
The importance of proper sample collection.
The renaissance in the use of blood-based biomarkers in diagnostic testing.
Podden och tillhörande omslagsbild på den här sidan tillhör Clinical Lab Products. Innehållet i podden är skapat av Clinical Lab Products och inte av, eller tillsammans med, Poddtoppen.
